What is more impressive and far less likely to be an outlier is the response seen in the higher dose levels after one dose.
“In cohorts 2 and 3 (8 and 12GBq, respectively), PSA reductions of greater than 35% were observed in almost 80% (78%, 7/9) of participants and PSA was reduced by over 80% in 44% (4/9) of participants so far.”
What is more impressive and far less likely to be an outlier is...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.72 |
Change
-0.170(2.47%) |
Mkt cap ! $2.119B | |||
| Open | High | Low | Value | Volume |
| $6.95 | $7.25 | $6.68 | $28.33M | 4.127M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6509 | $6.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.78 | 6841 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |